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 Is cinnamon safe and eff ective 
for treating lipid disorders? 
EVIDENCE-BASED ANSWER
A it’s probably safe, but its ef- fectiveness is uncertain. In-
suffi  cient evidence exists to determine 
whether cinnamon improves outcomes 
in patients with lipid disorders. In healthy 
patients without hyperlipidemia, cinna-
mon doesn’t change lipid levels but does 
cause mild gastrointestinal symptoms. 
In patients with diabetes, the bulk of the 
available evidence suggests cinnamon 
supplementation neither improves serum 
lipid levels nor causes signifi cant harm 
(strength of recommendation [SOR]: B, 
extrapolated from small randomized con-
trolled trials [RCTs] with heterogeneous 
results).
Evidence summary
No large trials with patient-oriented outcomes 
have evaluated cinnamon as a treatment for 
hyperlipidemia. One small RCT compared 
cinnamon with turmeric in 11 healthy indi-
viduals, ages 21 to 38 years, without diabetes 
or hyperlipidemia. 
Investigators administered 3 g cinnamon 
or 2.8 g turmeric daily for 4 weeks; they found 
no signifi cant change in fasting lipid values. 
Baseline lipid levels were 155 mg/dL for total 
cholesterol and 139 mg/dL for triglycerides. 
Clinical side eff ects of cinnamon included 
transient eructation (burping or refl ux), head-
ache, and a “burning stomach” sensation.1
RCT with diabetes patients 
shows some positive results
Four small RCTs whose primary purpose was 
to investigate the eff ects of cinnamon supple-
ments on blood glucose control in patients 
with diabetes also assessed blood lipid levels.
Th e fi rst RCT studied 30 men and 
30 women with type 2 diabetes, mean age 
52 years. Patients had had diabetes (con-
trolled with a sulfonylurea) for a mean of 
7 years, but had no other medical conditions. 
Investigators randomized them into 6 groups 
of 10 subjects, each taking 1, 3, or 6 g of cinna-
mon or an equal number of placebo capsules 
daily for 40 days, followed by a 20-day washout 
period. 
At 40 days, cinnamon at 3- and 6-g doses 
signifi cantly reduced total cholesterol (12%-
26% reduction; P<.05), low-density lipopro-
tein (LDL) (7%-27% reduction; P<.05), and 
triglycerides (23%-30% reduction; P<.05), 
but did not change high-density lipoprotein 
(HDL) levels. Cinnamon at the 1-g dose also 
reduced triglycerides and total cholesterol.2 
Investigators didn’t mention adverse eff ects.
Other studies fi nd no change in lipids, 
but no harm either
However, 3 subsequent RCTs with a total of 
181 patients found that cinnamon didn’t im-
prove fasting lipid profi les in patients with 
type 2 diabetes. 
❚ In the fi rst study, investigators random-
ized 25 postmenopausal women (mean age 
63 years) with type 2 diabetes (controlled on 
any of 3 classes of oral medication) to receive 
either 1.5 g cinnamon or placebo daily for 6 
weeks. Mean baseline lipid levels (total cho-
lesterol=190 mg/dL; HDL=50 mg/dL; LDL=
116 mg/dL; and triglycerides=113 mg/dL) did 
not change signifi cantly. Investigators didn’t 
mention adverse eff ects.3
❚ The second RCT, involving 79 patients 
(mean age 63 years) with type 2 diabetes on 
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oral therapy, also found that 3 g cinnamon dai-
ly didn’t change lipid profi les over 4 months. 
Baseline lipid levels were: total cholesterol=
209 mg/dL; HDL=56 mg/dL; LDL=135 mg/dL; 
and triglycerides=170 mg/dL. Investigators re-
ported no adverse eff ects.4
❚ The third RCT evaluated the eff ects of 
cinnamon supplementation compared with 
placebo on lipid levels and glycosylated hemo-
globin (HbA1c) for 77 individuals with type 2 
diabetes. Investigators recruited subjects of any 
age with diabetes controlled on a stable dose of 
oral agents and randomized them to receive ei-
ther 500 mg cinnamon or placebo twice daily. 
Subjects’ mean baseline cholesterol lev-
els were: total cholesterol=170 mg/dL; HDL=
44 mg/dL; LDL=102 mg/dL; and triglycer-
ides=132 mg/dL. Th ere was no diff erence 
from baseline in fasting glucose, cholesterol 
levels (total, HDL, or LDL), or triglycerides 
at monthly intervals over 3 months, nor was 
there any change in HbA1c from baseline to 
3 months.5
Recommendations
Th e American Diabetes Association states that 
cinnamon produces no benefi t for people with 
diabetes.6 Th e Mayo Clinic states that there is 
little evidence that cinnamon reduces choles-
terol levels, and does not recommend cinna-
mon as a treatment for high cholesterol.7        JFP
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•   The risk factors and comorbidities that contribute 
to and exacerbate acute gout fl ares
•  Criteria for establishing a diagnosis of gout 
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monitoring clinically meaningful urate lowering 
•   Means for optimizing patient adherence to long-term 
urate-lowering treatment
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